Skip to results
Modify your search
NARROW
1-20 of 88
Authors: Christel Herold-Mende
Sort by
Journal Article
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas
Get access
Ling Hai and others
Neuro-Oncology, noae251, https://doi.org/10.1093/neuonc/noae251
Published: 22 November 2024
Journal Article
Meningiomas: Sex-specific differences and prognostic implications of a chromosome X loss
Get access
Natalie Berghaus and others
Neuro-Oncology, noae239, https://doi.org/10.1093/neuonc/noae239
Published: 13 November 2024
Journal Article
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma
Get access
Franziska M Ippen and others
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 743–754, https://doi.org/10.1093/neuonc/noae238
Published: 12 November 2024
Journal Article
EXTH-54. COMBINATORIAL DRUG SCREENING IDENTIFIES CARFILZOMIB AND ENZALUTAMIDE FOR TREATING AGGRESSIVE MENINGIOMAS
Gerhard Jungwirth and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii249, https://doi.org/10.1093/neuonc/noae165.0985
Published: 11 November 2024
Journal Article
PATH-32. THE PROGNOSTIC IMPACT OF CDKN2A/B HETEROZYGOUS DELETIONS IN IDH-MUTANT GLIOMA
Franziska Maria Ippen and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii185–viii186, https://doi.org/10.1093/neuonc/noae165.0731
Published: 11 November 2024
Journal Article
DDDR-22. USE OF BIOPSY-DERIVED TUMOR ORGANOIDS FOR PERSONALIZED DRUG TESTING IN RECURRENT GLIOBLASTOMA
Christel Herold-Mende and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii130, https://doi.org/10.1093/neuonc/noae165.0507
Published: 11 November 2024
Journal Article
CTIM-04. MODULATION OF THE INTRATUMORAL IMMUNE MICROENVIRONMENT BY LOCAL THERAPY WITH NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Michael Burger and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii85, https://doi.org/10.1093/neuonc/noae165.0338
Published: 11 November 2024
Journal Article
EXTH-53. THE PHARMACOLOGICAL ATLAS OF MENINGIOMAS
Gerhard Jungwirth and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii248–viii249, https://doi.org/10.1093/neuonc/noae165.0984
Published: 11 November 2024
Journal Article
PATH-10. ACCELERATING COMPREHENSIVE CNS TUMOR MOLECULAR DIAGNOSTICS WITH RAPID-CNS2 AND MNP-FLEX: A PROSPECTIVE MULTI-CENTER VALIDATION
Areeba J Patel and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.713
Published: 18 June 2024
Journal Article
PATH-13. APPLICATIONS OF SPATIAL TRANSCRIPTOMICS FOR THE DIAGNOSTICS OF GLIOMAS
Michael Ritter and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v169–v170, https://doi.org/10.1093/neuonc/noad179.0643
Published: 10 November 2023
Journal Article
DNAR-13. TARGETING THE DNA DAMAGE RESPONSE IN GLIOBLASTOMA PROPAGATING CELLS: FROM MOLECULAR MECHANISMS TO PRECISION MEDICINE
Alexandros Pailas and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v101, https://doi.org/10.1093/neuonc/noad179.0379
Published: 10 November 2023
Journal Article
TMIC-69. TARGETING TUMOR-ASSOCIATED MACROPHAGES IN THE IMMUNE-MICROENVIRONMENT OF MENINGIOMAS
Catharina Lotsch and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v294, https://doi.org/10.1093/neuonc/noad179.1135
Published: 10 November 2023
Journal Article
EPCO-33. H3K4 METHYLATION IS A PREREQUISITE OF CELL FATE CHANGE DURING IDH-MUTANT GLIOMAGENESIS
Marilin Koch and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v131, https://doi.org/10.1093/neuonc/noad179.0496
Published: 10 November 2023
Journal Article
CNSC-09. CHI3L1 IS A MOLECULAR MARKER FOR GLIOBLASTOMA NETWORK CONNECTIVITY AND FUNCTIONALLY ORCHESTRATES TUMOR MICROTUBE FORMATION
Dirk Hoffmann and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v24, https://doi.org/10.1093/neuonc/noad179.0093
Published: 10 November 2023
Journal Article
BIOM-64. A PROGNOSTIC SCORING SYSTEM FOR IMMUNODEFICIENCY-ASSOCIATED PRIMARY CNS LYMPHOMAS: AN INTERNATIONAL MULTI-CENTER STUDY
Philipp Karschnia and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v19, https://doi.org/10.1093/neuonc/noad179.0075
Published: 10 November 2023
Journal Article
EXTH-71. AUTOMATED AND MULTIPLEXED COMBINATORIAL DRUG SCREENING OF FDA-APPROVED DRUGS IDENTIFIES POTENTIAL SYNERGISTIC DRUG PARTNERS FOR THE TREATMENT OF AGGRESSIVE MENINGIOMAS
Gerhard Jungwirth and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v240–v241, https://doi.org/10.1093/neuonc/noad179.0924
Published: 10 November 2023
Journal Article
IMMU-08. EOSINOPHILS ARE IMPORTANT MODULATORS OF AN IMMUNE-RESPONSIVE TUMOR-MICROENVIRONMENT IN GLIOBLASTOMA
Christel Herold-Mende and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v142–v143, https://doi.org/10.1093/neuonc/noad179.0540
Published: 10 November 2023
Journal Article
EPID-20. SEX-SPECIFIC DIFFERENCES IN MENINGIOMA SUBTYPES AND MUTATIONS – A RETROSPECTIVE ANALYSIS
Natalie Berghaus and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v119–v120, https://doi.org/10.1093/neuonc/noad179.0452
Published: 10 November 2023
Journal Article
SURG-41. PROGNOSTIC IMPACT OF EXTENDED RESECTIONS IN IDH MUTANT LOWER-GRADE DIFFUSE GLIOMA: RESULTS FROM A VOLUMETRIC ANALYSIS
Christine Jungk and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v271, https://doi.org/10.1093/neuonc/noad179.1039
Published: 10 November 2023
Journal Article
TMIC-46. SINGLE-CELL MAPPING OF HUMAN BREAST CANCER BRAIN METASTASES REVEALS PROGNOSTICALLY RELEVANT IMMUNE LANDSCAPES
Lena Jassowicz and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v288, https://doi.org/10.1093/neuonc/noad179.1112
Published: 10 November 2023
Advertisement
Advertisement